Can Ardelyx's (ARDX) Updated IBSRELA Outlook Reveal More About Its Long-Term Growth Potential? [Yahoo! Finance]
Ardelyx, Inc. (ARDX)
Last ardelyx, inc. earnings: 3/6 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.ardelyx.com/investor-relations
Company Research
Source: Yahoo! Finance
Kidney Week in Houston, highlighting its use for adults with chronic kidney disease on dialysis who need additional serum phosphorus control. The company's raised 2025 revenue guidance for IBSRELA, following a substantial year-over-year sales increase, revealed growing momentum in Ardelyx's commercial operations. We'll explore how the boost in IBSRELA performance and guidance updates may influence Ardelyx's evolving investment narrative. The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's. Ardelyx Investment Narrative Recap To be a shareholder in Ardelyx, you need confidence in the company's capacity to convert its innovation in kidney and gastrointestinal therapies into sustainable commercial success, primarily through IBSRELA and XPHOZAH. The new real-world data on XPHOZAH supports the product's differentiated profile, but it does not yet resolve the most important sho
Show less
Read more
Impact Snapshot
Event Time:
ARDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARDX alerts
High impacting Ardelyx, Inc. news events
Weekly update
A roundup of the hottest topics
ARDX
News
- Ardelyx (ARDX) Q3 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Ardelyx (NASDAQ:ARDX) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..MarketBeat
- Ardelyx (NASDAQ:ARDX) was downgraded by analysts at Wedbush from an "outperform" rating to a "neutral" rating.MarketBeat
- BTIG Maintains a Buy on Ardelyx, Inc (ARDX) [Yahoo! Finance]Yahoo! Finance
- Real-World Evidence Studies of XPHOZAH® (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney WeekGlobeNewswire
ARDX
Earnings
- 10/30/25 - Beat
ARDX
Sec Filings
- 11/25/25 - Form 4
- 11/25/25 - Form 4
- 11/25/25 - Form 4
- ARDX's page on the SEC website